利什曼蟲(chóng)IgG免疫熒光試劑盒

Leishmania IgG IFA Kit

廣州健侖生物科技有限公司

主要用途：用于檢測(cè)狗血清中的利什曼蟲(chóng)IgG抗體

產(chǎn)品規(guī)格：12 孔/張,10 張/盒

主要產(chǎn)品包括：包柔氏螺旋體菌、布魯氏菌、貝納特氏立克次體、土倫桿菌、鉤端螺旋體、新型立克次體、恙蟲(chóng)病、立克次體、果氏巴貝西蟲(chóng)、馬焦蟲(chóng)、牛焦蟲(chóng)、利什曼蟲(chóng)、新包蟲(chóng)、弓形蟲(chóng)、貓流感病毒、貓冠狀病毒、貓皰疹病毒、犬瘟病毒、犬細(xì)小病毒等病原微生物的 IFA、MIF、ELISA試劑。

利什曼蟲(chóng)IgG免疫熒光試劑盒

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、西尼羅河、立克次體、無(wú)形體、蜱蟲(chóng)、恙蟲(chóng)、利什曼原蟲(chóng)、RK39、漢坦病毒、深林腦炎、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢(xún)

歡迎咨詢(xún)2042552662

二維碼掃一掃

【公司名稱(chēng)】 廣州健侖生物科技有限公司
【】    楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化】

《實(shí)驗(yàn)生物及醫(yī)學(xué)》期刊主編史蒂芬?古德曼博士說(shuō)：“帕特等人的研究利用小鼠基因剔除的方式來(lái)研究丙酮酸脫氫酶復(fù)合體在胰臟β-細(xì)胞發(fā)育所扮演的角色。他們的研究證明丙酮酸脫氫酶復(fù)合體直接影響β-細(xì)胞的細(xì)胞大小及可塑性。”
盧森堡大學(xué)盧森堡中心系統(tǒng)生物醫(yī)學(xué)研究院(LCSB)的科學(xué)家們已經(jīng)將皮膚細(xì)胞神經(jīng)元重編程植入到小鼠大腦并*維持長(zhǎng)期穩(wěn)定。植入后6個(gè)月，神經(jīng)元功能上*整合到大腦。這一成功，持久穩(wěn)定，神經(jīng)元的植入為將來(lái)治療帕金森病人智力時(shí)，用健康的神經(jīng)元替換患病的神經(jīng)元增加希望。
圖片顯示大腦切片部分，其中被移植的誘導(dǎo)神經(jīng)干細(xì)胞*整合到大腦的神經(jīng)元網(wǎng)絡(luò)(藍(lán)色)發(fā)育成一個(gè)復(fù)雜的功能性神經(jīng)元。
LCSB的測(cè)試中，馬克斯普朗克研究所和大學(xué)醫(yī)院明斯特和比勒費(fèi)爾德大學(xué)的研究小組和同事成功將由皮膚細(xì)胞進(jìn)行重編程誘導(dǎo)的神經(jīng)元在小鼠大腦中創(chuàng)建了穩(wěn)定的神經(jīng)組織。產(chǎn)生神經(jīng)元的干細(xì)胞研究者的技術(shù)，或者更具體的說(shuō)誘導(dǎo)神經(jīng)元干細(xì)胞(iNSC)，在培養(yǎng)皿中培養(yǎng)的宿主皮膚細(xì)胞在很大程度上改善了植入細(xì)胞的相容性。
治療的小鼠沒(méi)有顯示出不利的副作用，甚至在植入六個(gè)月后成為大腦的海馬和皮質(zhì)區(qū)域。植入神經(jīng)元*整合到大腦的復(fù)雜網(wǎng)絡(luò)。該神經(jīng)元表現(xiàn)出正?；钚圆⑶彝ㄟ^(guò)新形成的突觸——神經(jīng)細(xì)胞之間的接觸點(diǎn)連接到原始腦細(xì)胞。

Dr. Stephen Goodman, editor-in-chief of Experimental Biology and Medicine, said: "Pat et al's study explored the role of the pyruvate dehydrogenase complex in the pancreatic β-cell development using gene knockout in mice. Their research shows that pyruvate dehydrogenase complex directly affects the cell size and plasticity of β-cells. "
Scientists at the Luxembourg Center for System Biomedicine Research (LCSB) at the University of Luxembourg have already implanted skin-cell neurons into the mouse brains and have maintained long-term stability for the first time. Six months after implantation, neurons functionally integrate compley into the brain. This success, lasting stability, neuronal implantation for the future treatment of Parkinson's patients inligence, with healthy neurons to replace diseased neurons increase hope.
The picture shows a section of the brain that grows into a complex functional neuron in which the transplanted neural stem cells are fully integrated into the brain's neuronal network (blue).
In the latest LCSB test, research groups and colleagues at the Max Planck University and the University Hospital in Münster and Bielefeld succeeded in creating neurons that are reprogrammed by skin cells to create stable Nerve tissue. Stem Cells Producing Neurons Researchers' technology, or more specifically, induction of neuronal stem cells (iNSCs), host skin cells cultured in petri dishes greatly improve the compatibility of the implanted cells.
The treated mice showed no adverse side effects and became brain regions of the hippocampus and cortex even six months after implantation. Implanted neurons are fully integrated into the complex network of the brain. The neurons exhibit normal activity and are connected to the naive brain cells through the contact points between the newly formed synaptic-neurons.